Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone
Plus news about Regeneron. Summit Therapeutics to test cancer drug with Datroway: The biotech agreed to partner with AstraZeneca and Daiichi Sankyo on a clinical trial collaboration, testing its Trop-2-directed antibody-drug ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.